Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 29Thoracic 9Gastrointestinal 6Dermatologic 6Head & Neck 3Gynecologic 2Other solid neoplasm 1

Conditions

Squamous Cell Carcinoma of Head and Neck 88Head and Neck Neoplasms 42Carcinoma, Non-Small-Cell Lung 32Melanoma 27Carcinoma, Renal Cell 24Colorectal Neoplasms 18Carcinoma, Transitional Cell 16Carcinoma, Hepatocellular 14Ovarian Neoplasms 13Neoplasm Metastasis 13Carcinoma, Squamous Cell 13Triple Negative Breast Neoplasms 11Stomach Neoplasms 11Carcinoma, Merkel Cell 11Uterine Cervical Neoplasms 10Pancreatic Neoplasms 10Nasopharyngeal Carcinoma 10Oropharyngeal Neoplasms 8Thyroid Neoplasms 7Urinary Bladder Neoplasms 6Small Cell Lung Carcinoma 6Sarcoma 6Recurrence 6Breast Neoplasms 6Mouth Neoplasms 5Lymphoma 5Lung Neoplasms 5Esophageal Neoplasms 5Endometrial Neoplasms 5Salivary Gland Neoplasms 4

Interventions

pembrolizumab 10atezolizumab 4Drug Therapy 4Nivolumab 3Filgrastim 3Cetuximab 3Carboplatin 3cemiplimab 2belinostat 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Fluorouracil 2Counseling 2Bupropion 2Bortezomib 2utomilumab 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1tremelimumab 1tocilizumab 1tanespimycin 1seribantumab 1poly ICLC 1pentetreotide 1pazopanib 1oblimersen 1motexafin gadolinium 1mogamulizumab 1liposomal doxorubicin 1ixabepilone 1gallium Ga 68 dotatate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Kidney Neoplasms × Nivolumab × Head & Neck × Clear all
NCT04157985 2025-12-11

Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors

University of Pittsburgh

Phase 3 Completed
161 enrolled
DermatologicGastrointestinalGenitourinaryGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Kidney Neoplasms, Melanoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Cholangiocarcinoma

NCT05704985 2025-05-29

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

DEKA Biosciences

Phase 1 Active not recruiting
39 enrolled
DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Kidney Neoplasms, Neoplasms, Pancreatic Neoplasms, Skin Neoplasms, Colorectal Neoplasms

NCT02946671 2020-03-06

Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients

Osaka University

Phase 1 Completed
16 enrolled
GastrointestinalGenitourinaryHead & NeckThoracic

Esophageal Neoplasms, Kidney Neoplasms, Lung Neoplasms, Mouth Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡